# Grand Pharma joint venture invests $7.5M in Conavi Medical

A joint venture of Grand Pharmaceutical (via China Grand Enterprise) subscribed for approximately 1.0431 million preferred shares of Conavi Medical Inc for about $7.5 million. The joint venture also obtained exclusive distribution rights for Conavi's Foresight ICE and Novasight Hybrid products in Greater China for 20 years.

- Type: Investment
- Announced: 2017-11-15
- Where: Canada
- Value: $7.50M
- Status: announced
- Products: Foresight ICE series, Novasight Hybrid series
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Grand Pharmaceutical Group](https://endata.com/companies/28076.md)
- [Conavi Medical Inc](https://endata.com/companies/28137.md) (target)

## Sources

- [beta.zhitongcaijing.com](http://beta.zhitongcaijing.com/content/detail/91198.html), 2017-11-15: "根据认购协议，合营公司将累计认购约104.31万股Conavi的优先股，代价约750万美元。"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.